Ze-Qi Xu
Geen lopende functies
Profiel
Ze-Qi Xu served as Vice President-Strategic Drug Development at MediChem Life Sciences, Inc. from 2000 to 2002, and as Chief Scientific Officer & Executive VP at Advanced Life Sciences Holdings, Inc. from 2002 to 2011.
Xu holds a doctorate degree from Shanghai Institute of Organic Chemistry, a graduate degree from Shanghai Jiao Tong University, and an undergraduate degree from Jiangxi Normal University.
Eerdere bekende functies van Ze-Qi Xu
| Bedrijven | Functie | Einde |
|---|---|---|
| ADVANCED LIFE SCIENCES HOLDINGS, INC. | Hoofd Techniek/Wetenschap/O&O | 05-05-2011 |
MediChem Life Sciences, Inc.
 MediChem Life Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Part of DGI Resolution, Inc., MediChem Life Sciences, Inc. provides research and drug discovery services. The company is based in Woodridge, IL. The company was founded in 1987 by Michael T. Flavin. MediChem Life Sciences was acquired by deCODE genetics, Inc. on March 18, 2002 for $52.85 million. | Corporate Officer/Principal | 01-09-2002 |
Opleiding van Ze-Qi Xu
| Shanghai Jiao Tong University | Graduate Degree |
| Jiangxi Normal University | Undergraduate Degree |
| Shanghai Institute of Organic Chemistry | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Advanced Life Sciences Holdings, Inc.
 Advanced Life Sciences Holdings, Inc. BiotechnologyHealth Technology Advanced Life Sciences Holdings, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of novel drugs in therapeutic areas of infection, cancer and inflammation. Its product candidate, Restanza, is a novel once-a-day oral antibiotic in late-stage development for the treatment of life-threatening infections including community-aquired bacterial pneumonia and biodefense pathogens including anthrax, plague and tularemia. The company was founded by Michael T. Flavin on January 1, 1999 and is headquartered in Woodridge, IL. | Health Technology |
MediChem Life Sciences, Inc.
MediChem Life Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Part of DGI Resolution, Inc., MediChem Life Sciences, Inc. provides research and drug discovery services. The company is based in Woodridge, IL. The company was founded in 1987 by Michael T. Flavin. MediChem Life Sciences was acquired by deCODE genetics, Inc. on March 18, 2002 for $52.85 million. | Commercial Services |